Ligand profile
WXM
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_03128 — Beta-lactamase CTX-M-2
Identifiers
Database identifiers and provenance.
- Ligand ID
WXM- PDB
6v7h- UniProt (similar protein)
Q9L5C7- Target protein
- KP13_03128
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 116.1
- −1 ≤ LogP ≤ 5 -0.11
- MW ≤ 500 Da 314.1
- LogP ≤ 5 -0.11
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 116.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
[B-]1([C@H](CC[C@H](O1)CC(=O)O)NC(=O)Cc2cccs2)(O)O[B-]1([C@H](CC[C@H](O1)CC(=O)O)NC(=O)Cc2cccs2)(O)O
InChI=1S/C12H17BNO6S/c15-11(7-9-2-1-5-21-9)14-10-4-3-8(6-12(16)17)20-13(10,18)19/h1-2,5,8,10,18-19H,3-4,6-7H2,(H,14,15)(H,16,17)/q-1/t8-,10-/m0/s1InChI=1S/C12H17BNO6S/c15-11(7-9-2-1-5-21-9)14-10-4-3-8(6-12(16)17)20-13(10,18)19/h1-2,5,8,10,18-19H,3-4,6-7H2,(H,14,15)(H,16,17)/q-1/t8-,10-/m0/s1
ZHOJKQMRDCUTLH-WPRPVWTQSA-NZHOJKQMRDCUTLH-WPRPVWTQSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00144' 'PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand WXM →
- PDB RCSB structure 6v7h →
- UniProt UniProt Q9L5C7 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “WXM”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03128.
PDB 51
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 6
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).